Blood flow restriction therapy after hip surgery
Postoperative Blood Flow Restriction Training Following Hip Arthroscopy: A Randomized Clinical Trial
This study is testing if a special therapy that restricts blood flow can help people recover stronger and faster after hip surgery for certain injuries.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 56 (estimated) |
| Ages | 18 Years to 40 Years |
| Sex | All |
| Sponsor | Rush University Medical Center Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT04113759 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of blood flow restriction (BFR) therapy in enhancing muscle growth and strength recovery in patients undergoing hip arthroscopy for femoral acetabular impingement and labral tears. Participants will be randomly assigned to receive either BFR therapy or a sham treatment, with their progress monitored through strength testing, leg measurements, and MRI assessments over a year. The study aims to determine if BFR can improve rehabilitation outcomes compared to standard recovery methods.
Who should consider this trial
Good fit: Ideal candidates are English-speaking adults aged 18-40 scheduled for primary hip arthroscopy due to labral pathology or femoral acetabular impingement.
Not a fit: Patients over 40, those with prior hip or knee surgeries, or individuals with certain medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved muscle recovery and rehabilitation outcomes for patients after hip arthroscopy.
How similar studies have performed: Other studies have shown promising results with blood flow restriction therapy in various rehabilitation settings, suggesting potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients 18-40 * English-speaking * Clinical and radiographic examination (MRI) consistent FAIS and/or labral pathology, and are schedule for primary hip arthroscopy * Written and informed consent for study participation Exclusion Criteria: * Patients younger than 18 or older than 40 years of age * Non-native English speaker * Revision surgery or prior history of ipsilateral hip or knee surgery * Inability to comply with the proposed follow-up clinic visits * Patients lacking decisional capacity * Patients with a history of deep vein thrombosis, pulmonary embolism, or known clotting disorder or hypercoagulable state * Pregnant or breast-feeding women. Pregnancy as determined by a positive pregnancy test prior to procedure. Females of childbearing potential must agree to use an acceptable birth control method during study participation. * Worker's compensation patients * Any clinically significant finding that would place the patient at health risk, impact the study, or affect the completion of the study * Any psychiatric illness that would prevent comprehension of the details and nature of the study and interfere with follow-up clinic visits
Where this trial is running
Chicago, Illinois
- Rush University Medical Center — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Jorge Chahla, MD PhD — Rush University Medical Center
- Study coordinator: Carla M. Edwards, PhD
- Email: carla_edwards@rush.edu
- Phone: 312-563-5735
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.